Newsbenzinga
What's Going On With Capricor Therapeutics Stock Monday?
· Published
Article summary
Capricor Therapeutics (CAPR) shares top-line HOPE-3 extension data for Deramiocel in DMD ahead of its Nov 22 FDA PDUFA date.
An excerpt from the original article.
Comments —
Loading comments…